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Objective: To evaluate the role of preradiosurgical embolization on obliteration rate, 
reduction of size, irradiation dose, and neurological outcome, in 90 patients presenting 
large arteriovenous malformations (AVMs).
Methods: Between October 1993 and October 2006, 90 radiosurgical procedures 
were performed to treat brain AVMs Spetzler–Martin (SM) grades III, IV, and V at the 
Department of Radiosurgery and Radiology of the Real e Benemérita Associação 
Portuguesa de Beneficência de São Paulo, São Paulo, Brazil. Fifty-nine patients had 
embolization before radiosurgery and complete clinical and radiologic follow-up for at 
least 3 years. Inclusion criteria were as follow: SM grades III, IV, and V AVMs, no previ-
ous treatment, and clinical and radiological (angiogram and MRI) follow-up for at least 
3 years. Obliteration rate, reduction of size, irradiation dose, and neurological outcome 
were compared in these two cohorts of patients. Mann–Whitney test, “Student’s t-test,” 
and χ2 tests were used for statistical analysis, as appropriate. The level of significance 
was determined at p < 0.05.
results: The mean size of the AVMs that underwent embolization was significantly 
greater when compared with non-embolized group (p < 0.05). Embolization significantly 
reduced the AVM diameter. Irradiation dose was significantly smaller in the embolized 
group (p <  0.05). No significant differences in final clinical outcomes, postprocedural 
radiological findings, rate of occlusion, and need for additional procedures were observed 
between the two groups (p < 0.05).
conclusion: Preradiosurgical embolization of large AVMs does not result in impaired 
obliteration rate compared with cases treated with radiosurgery alone. It did not add 
further morbidity and presented benefits of reducing size of the AVMs. Preradiosurgical 
embolization may facilitate the coverage of the AVM with the effective irradiation 
dose. Combined management may be effective for selected large lesions considered 
unsuitable for radiosurgery and otherwise untreatable.
Keywords: arteriovenous malformation, embolization, radiosurgery, staged embolization, surgery
TaBle 2 | Ocurrence of hemorraghe at clinical presentation (n = 90).
hemorraghe n %
Absente 49 54.4
Intraparenchymal 21 23.3
Intraparenchymal and intraventricular 15 16.7
Subarachnoid hemorraghe 02 2.2
Subarachnoid hemorraghe and Intraparenchymal 02 2.2
Intraparenchymal, intraventricular and 
subarachnoid hemorraghe
01 1.1
TaBle 1 | clinical presentation of the patients (n = 90).
clinical presentation n %
Paresis 41 45.6
Headache 35 38.9
Seizures 33 36.7
Incidental 07 7.8
Cognitive dysfunction 03 1.1
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inTrODUcTiOn
Intracranial arteriovenous malformations (AVMs) constitute a 
formidable medical challenge. When amenable, surgical treat-
ment is the best option because it affords immediate cure and 
prevents hemorrhage. However, surgery is not always feasible 
and frequently additional therapeutic modalities, such as embo-
lization and radiotherapy, are required. Radiosurgery may be 
employed as an alternative to microsurgery in small lesions or as 
a part of a combined treatment of Spetzler–Martin (SM) grades 
III, IV, and V AVMs. However, it does not always obliterate the 
nidus completely (1–21). The occlusion rate varies proportionally 
with the inverse of the AVM’s diameter. Therefore, large AVMs 
are not suitable for radiosurgical treatment unless their size is 
reduced.
In thesis, initial volume reduction with endovascular embo-
lization is useful in large AVMs and may facilitate complete 
obliteration with therapeutically effective dose. However, the 
role of preradiosurgical embolization is still to be definitively 
established. Most of the reports actually indicate that it reduces 
the obliteration rate and increases morbidity (2, 6, 14, 22), and 
many authors indeed do not recommend preradiosurgical embo-
lization. Therefore, a large number of patients are left untreated.
In this paper, we retrospectively investigated 90 patients pre-
senting III, IV, and V SM grade AVMs, treated with or without 
preradiosurgical embolization between 1993 and 2006, aiming to 
evaluate the role of this procedure on obliteration rate, reduction 
of size, need for additional procedures, irradiation dose, and 
neurological outcome.
MaTerials anD MeThODs
Between October 1993 and October 2006, 90 radiosurgical 
procedures were performed to treat brain AVMs SM grades III, 
IV, and V, at the Department of Radiosurgery and Radiology of 
the Real e Benemérita Associação Portuguesa de Beneficência de 
São Paulo, São Paulo, Brazil. A multidisciplinary team consist-
ing of vascular neurosurgeons, endovascular therapists, and 
radiosurgeons initially was involved in this study. Of these 90 
patients, 59 had embolization before radiosurgery and complete 
clinical and radiologic follow-up for at least 3 years. AVMs were 
classified according to the SM grading system by neurosurgeons, 
interventional radiologists, and radiosurgeons.
Forty-six (51.1%) patients were female and 44 (48.9%) were 
male. Mean age was 30.6 years. Asymptomatic AVMs are com-
posed of 7.8% (seven cases). Inclusion criteria were SM grades III, 
IV, and V AVMs, AVMs with no previous treatment, and patients 
with clinical and radiological (angiogram and MRI) follow-up for 
at least 3 years. From the original cohort of 105 patients, 15 did 
not meet the inclusion criteria.
Clinical presentation is detailed in Table 1. Forty-one (45.6%) 
patients presented with hemorrhage (Table 2). Fifty-two patients 
(57.8%) presented angioarchitectural abnormalities, including 
intranidal aneurysms, arterial or venous stenosis, and venous 
ectasia. Occlusion rate, irradiation doses, clinical morbidity, 
and radiological complications were evaluated and compared 
between the two groups.
endovascular Procedure
The goals of the procedure were to decrease the size of lesion 
and target lesions that would increase the risks for hemorrhage, 
such as aneurysms. All procedures were carried out under gen-
eral anesthesia. A 5- or 6-French guide catheter was introduced 
in the femoral artery and placed in the internal carotid or 
vertebral artery.
Angiography was then performed, followed by superselec-
tive catheterization of the AVM feeders, using an Ultraflow 
HPC™ microcateter (1.5  Fr) (Micro Therapeutics, Inc., Irvine, 
CA, USA), which allowed a better understanding of the AVM 
angioarchitectural findings. Intranidal catheter position was 
achieved whenever it was feasible. Lipiodol and Histoacryl 
(Braun Melsugen SA, S. Gonçalo, RJ, Brazil) were used as agents 
of embolization. No more than one-third of the lesion was 
embolized per  session. Every effort was made to target feeders 
harboring intranidal aneurysms. In cases that need additional 
sessions, the interval between them was at least 30 days. Dynamic 
subtraction fluoroscopy was employed to display the nidus and 
feeders, as well as the cast.
radiosurgery
The planning was done using Brain Scan, Image Fusion 5.3.1 
(BrainLab, Munich, Germany) based on the combination of 
the angiographic data, contrast-enhanced CT images, and 
thin-sliced MRI. The selection of the radiation dose dependent 
on location and target volume. The maximal dose varied from 
1200 to 2500 cGy, at an isodose of 80%. No difficulties related 
to the previous partial embolization of the lesion were observed. 
Radiation was delivered using Varian 6 MV system (Varian, Inc., 
Palo Alto, CA, USA).
Follow-up
Patients were followed up with clinical examinations for at least 
3 years after treatment. Clinical follow-up was carried out in the 
3rd, 6th, and 12th months, and once per year thereafter. MRI was 
TaBle 5 | Transient clinical complications in the embolized group.
clinical complications n %
Hemiparesis 5 8.4
Seizures 1 1.6
Wallenberg syndrome 1 1.6
TaBle 4 | Permanent clinical complications in the embolized group.
clinical complications n %
Hemiparesis 4 6.7
Hemiparesis + disfasia 1 1.6
Hemifacial anesthesia + diplopia + vertigo 1 1.6
Hemiparesis + disartria + cerebellar syndrome 1 1.6
Deafness 1 1.6
TaBle 3 | Volume before rDs and irradiation does in the two groups.
embolization n Mean sD Values p
Minimum Maximum
Volume 
before 
RDS
No 31 8.17 8.66 0.33 33.60 0.013a
Yes 59 13.36 10.63 0.38 52.54
Irradiation 
dose
No 31 1726.00 314.87 1300.00 2500.00 0.029b
Yes 59 1686.00 266.56 1200.00 2500.00
aMann–Whitney test.
bStudent’s t-test.
RDS, radiosurgery.
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used to follow the patients once per year. Cerebral angiography 
was performed 3 years after treatment.
statistical analysis
Mann–Whitney test, “Student’s t-test,” and χ2 tests were used for 
statistical analysis, as appropriate. The level of significance was 
determined at p < 0.05.
resUlTs
Arteriovenous malformations were located in the frontal lobe 
(n  =  18; 20%), parietal lobe (n  =  15; 16.7%), basal ganglia 
(n = 15; 16.7%), thalamus (n = 12; 13.3%), temporal lobe (n = 7; 
7.8%), ventricles (n = 7; 7.8%), occipital lobe (n = 6; 6.7%), insula 
(n = 5; 5.6%), cerebellum (n = 4; 4.4%), and corpus callosum 
(n = 1; 1.1%).
Table  1 summarizes the clinical data. Motor deficit was 
presented in 41 patients (45.6%), whereas asymptomatic cases 
were composed of 7.8% (n =  7). Forty-nine patients (60%) 
presented grade III AVMs. Embolization significantly reduced 
the AVM diameter and AVM’s grade. Embolized AVMs pre-
sented greater volume than non-embolized ones (p = 0.013). 
Irradiation dose was significantly smaller in the embolized 
group (p = 0.029) (Table 3).
Permanent complications occurred in eight (13.5%) patients 
in the embolization group (Table  4). Two motor deficits were 
related to bleeding. Ischemic events occurred in six patients. 
Transient clinical complications occurred in seven patients 
(11.7%) in the embolized group (Table  5). Complications in 
the non-embolized group were related with biological effects of 
radiation and were managed using corticoids. Delayed radiation 
induced a permanent complication in one patient. Two patients 
experienced hemorrhage during the latency period without 
related neurological deficits. Additional radiosurgical procedure 
was performed in 7 (22.6%) in the non-embolized group and in 
25 patients (42.4%) of the embolized group.
No significant differences in final morbidity, postprocedural 
radiological findings, rate of occlusion, and need for additional 
procedures were observed between the two groups.
DiscUssiOn
Grades I and II AVMs may be effectively treated either by sur-
gery or radiosurgery; however, management of larger lesions 
represents a formidable challenge and most often requires 
multiple treatment strategies (5, 14, 20, 23, 24). In this setting, 
initial endovascular embolization, aiming to decrease AVM’s size, 
combined with stereotactic radiosurgery represents an empirical 
option. Nonetheless, the benefits and advantages of preradiosur-
gical embolization have not been defined thus far (2, 3, 9, 11, 24). 
Indeed, the drawbacks of preradiosurgical embolization have 
been often emphasized (2, 3, 9, 11, 20).
In several studies, preradiosurgical nidus embolization was 
associated with lower obliteration rate, higher morbidity, and 
worse outcomes (18). Andrade-Souza et  al. (25) demonstrated 
that obliteration occurred in 47% of patients treated with embo-
lization compared with 70% of the radiosurgery-alone group. 
Schlienger et  al. (18) verified that the obliteration rate reaches 
54% in cases with preradiosurgical embolization and 71% in 
radiosurgery-alone cohort. Other study showed obliteration rates 
of 26 and 76% for embolized and non-embolized lesions, respec-
tively (15). Pollock et al. found that preradiosurgical embolization 
was considered as a negative factor for obliteration and optimal 
results (26). Xu et al. meta-analyzed 10 studies that demonstrated 
no benefits for preradiosurgical embolization; however, there 
were significant publication bias (27).
Various factors have been considered as responsible for such 
unsatisfactory outcomes. Indeed, ineffective embolization with-
out reduction of AVM’s total volume may difficult radiosurgical 
targeting (6, 11, 22). Moreover, partial embolization may cause 
dissociation of the AVM into distinct compartments, impairing 
conformal radiosurgical planning (6, 11, 18, 21).
Conversely, other studies have shown different conclusions. 
Izawa et al. (11) reported that preradiosurgical embolization did 
not result in improved occlusion or higher complications rates. 
Indeed, it may facilitate complete coverage with effective dose. 
Blackburn et al. (2) conclude that staged preradiosurgical endo-
vascular embolization provides an effective means of treating 
large AVMs not amenable to surgical or radiosurgical-alone treat-
ments. The outcomes and complication rates compare favorably 
to the results of other reported therapeutic strategies (2).
In this study, the obliteration rate and long-term morbidity 
after combined management of AVMs with embolization and 
FigUre 1 | a 37-year-old female presents with a grade iV frontal lobe aVM. (a) RMI depicts a right frontal lobe AVM. (B) Anteroposterior angiogram view.  
(c) Anteroposterior angiogram view after embolization displays a significant reduction of the AVM’s size. Anteroposterior (D) and lateral (e) angiogram views 
conveying total obliteration of the AVM 2 years radiosurgery (1700 cGy).
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radiosurgery do not significantly differ. The greater mean nidus 
volume in the embolization group may imply that embolization 
was mainly indicated in larger lesions, and therefore, it can be 
speculated that reduction of the nidus’ size might play an impor-
tant role in the overall effectiveness of treatment. Large AVMs 
were converted to smaller ones, feasible to radiosurgery and 
otherwise untreatable lesions (Figures 1 and 2).
Notwithstanding, combined management may result in 
associating the intrinsic morbidity of both procedures (11). 
Nonetheless, no major neurologic deterioration was observed 
after embolization, probably reflecting careful case selection and 
non-aggressive strategy of endovascular management. Aggressive 
embolization of a large AVM in a single session may augment the 
risks (5, 11, 22, 23, 25, 28).
The reported rate of long-term postradiosurgical complica-
tions in previously embolized cases was higher, equal (9, 11), 
or lower (2, 13) than in cases treated with radiosurgery alone 
(11). In our study, the long-term morbidity rate did not differ 
significantly between the groups with and without previous 
embolization.
A substantial benefit of preradiosurgical embolization was 
the overall reduction of the irradiation dose, even considering 
the additional radiation dose required in further radiosurgical 
procedures. Significant reduction of size was probably respon-
sible for the complete coverage of the nidus with the effective 
dose. Even though, the occlusion rates did not differ significantly, 
several lesions that could be left untreated were effectively man-
aged and occluded.
limitations of the study
This is a retrospective study, and as such, it is susceptible to sys-
tematic errors (bias). In the embolized group, AVMs were larger 
than in radiosurgery-only group, which may introduce selection 
bias, even though, there were no statistical differences between 
the two groups. A subgroup analysis has not been performed, for 
small or large AVMs, due the insufficient number of cases, which 
may underpower the study.
In this series, mean patient age was 30.6 years. The follow-up 
period of 3 years is relatively short and may be difficult to make 
definitive recommendations for this particular group, as younger 
patients have higher chance of rebleed in the long term, after 
non-surgical treatment.
We found no statistical differences regarding percentage of 
occlusion and need for further procedures, results that are dif-
ferent from other studies and which may represent an additional 
contribution to the literature in this controversial matter.
FigUre 2 | a 21-year-old male with a parietal lobe hemorrhage. Angiogram diagnosed a grade IV AVM. (a) Anteroposterior view. (B) Lateral view. Four years 
after radiosurgery (2200 cGy) angiogram evidenced total occlusion. (c) Anteroposterior view. (D) Lateral view.
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cOnclUsiOn
This study has demonstrated that partial embolization of intrac-
ranial AVMs before stereotactic radiosurgery does not result in 
statistically significant impaired obliteration rate compared with 
cases treated with radiosurgery alone. Preradiosurgical emboliza-
tion may present benefits of reducing size of the AVMs and may 
facilitate the coverage of the AVM with the effective irradiation 
dose. Thus, combined management may be effective for selected 
and otherwise deemed untreatable cases.
ehTics sTaTeMenT
The study was approved by the Comissão de Etica para Aanalise 
de Projetos de Pesquisa (CAPPesq) – 612/06. All patients signed 
an informed consent form.
aUThOr cOnTriBUTiOns
All the authors participated in the revision and supervision of 
the manuscript.
reFerences
1. Andrade-Souza YM, Ramani M, Scora D, Tsao MN, terBrugge K, Schwartz ML. 
Emboilization before radiosurgery reduces the obliteration rate of arteriove-
nous malformations. Neurosurgery (2007) 60:443–51. doi:10.1227/01.NEU. 
0000255347.25959 
2. Blackburn SL, Ashley WW, Rich KM, Simpson JR, Drzymala RE, Ray WZ, 
et  al. Combined endovascular embolization and stereotactic radiosurgery 
in the treatment of large arteriovenous malformations. J Neurosurg (2011) 
114(6):1758–67. doi:10.3171/2011.1.JNS10571 
3. Chang TC, Shirato H, Aoyama H, Ushikoshi S, Kato N, Kuroda S, et  al. 
Stereotactic irradiation for intracranial arteriovenous malformation using 
stereotactic radiosurgery or hypofractionated stereotactic radiotherapy. Int 
J Radiat Oncol Biol Phys (2004) 60:861–70. doi:10.1016/j.ijrobp.2004.04.041 
4. Colombo F, Pozza F, Chierego G, Casentini L, De Luca G, Francescon P. Linear 
accelerator radiosurgery of cerebral arteriovenous malformations: an update. 
Neurosurgery (1994) 34:14–21. doi:10.1227/00006123-199401000-00004 
5. Deruty R, Pelissou-Guyotat I, Amat D, Mottolese C, Bascoulergue Y, 
Turjman F, et al. Complications after multidisciplinary treatment of cerebral 
arteriovenous malformations. Acta Neurochir (Wien) (1996) 138:119–31. 
doi:10.1007/BF01411350 
6. Deruty R, Pelissou-Guyotat I, Morel C, Bascoulergue Y, Turjman F. Reflections 
on the management of cerebral arteriovenous malformations. Surg Neurol 
(1998) 50:245–56. doi:10.1016/S0090-3019(98)00082-2 
7. Ellis TL, Friedman WA, Bova FJ, Kubilis PS, Buatti JM. Analysis of treatment 
failure after radiosurgery for arteriovenous malformations. J Neurosurg (1998) 
89:104–10. doi:10.3171/jns.1998.89.1.0104 
8. Friedman WA. Radiosurgery for arteriovenous malformations: the University 
of Florida experience. In: Kondziolka D, editor. Radiosurgery. (Vol. 4), Basel: 
Karger (2002). p. 12–8.
9. Friedman WA, Bova FJ, Bollampally S, Bradshaw P. Analysis of factors 
predictive of success or complications in arteriovenous malformation radio-
surgery. Neurosurgery (2003) 52:296–308. doi:10.1227/01.NEU.0000043692. 
51385.91 
6Sousa et al. The Role of Preradiosurgical Embolization
Frontiers in Surgery | www.frontiersin.org June 2016 | Volume 3 | Article 37
10. Inoue HK, Ohye C. Hemorrhage risks and obliteration rates of arteriove-
nous malformations after gamma knife radiosurgery. J Neurosurg (2002) 
97(Suppl):474–6. 
11. Izawa M, Chernov M, Hayashi M, Iseki H, Hori T, Takakura K. Combined 
management of intracranial arteriovenous malformations with embolization 
and gamma knife radiosurgery: comparative evaluation of the long-term 
results. Surg Neurol (2009) 71(1):43–52. doi:10.1016/j.surneu.2007.11.016 
12. Izawa M, Hayashi M, Chernov M, Nakaya K, Ochiai T, Murata N, et  al. 
Long-term complications after gamma knife surgery for arteriovenous 
malformations. J Neurosurg (2005) 102(Suppl):34–7. doi:10.3171/jns.2005. 
102.s_supplement.0034 
13. Liscak R, Vladyka V, Simonova G, Urgosík D, Novotný J Jr, Janousková L, et al. 
Arteriovenous malformations after Leksell gamma knife radiosurgery: rate of 
obliteration and complications. Neurosurgery (2007) 60:1005–16. 
14. Lunsford LD, Kondziolka D, Flickinger JC, Bissonette DJ, Jungreis CA, 
Maitz AH, et  al. Stereotactic radiosurgery for arteriovenous malformations 
of the brain. J Neurosurg (1991) 75:512–24. doi:10.3171/jns.1991.75.4.0512 
15. Miyawaki L, Dowd C, Wara W, Goldsmith B, Albright N, Gutin P, et al. Five 
year results of LINAC radiosurgery for arteriovenous malformations: outcome 
for large AVMs. Int J Radiat Oncol Biol Phys (1999) 44:1089–106. doi:10.1016/
S0360-3016(99)00102-9 
16. Pollock BE, Flickinger JC, Lunsford LD, Bissonette DJ, Kondziolka D. Hemorrhage 
risk after stereotactic radiosurgery of cerebral arteriovenous malformations. 
Neurosurgery (1996) 38:652–61. doi:10.1097/00006123-199604000-00004 
17. Pollock BE, Flickinger JC. A proposed radiosurgery-based grading system 
for arteriovenous malformations. J Neurosurg (2002) 96:79–85. doi:10.3171/
jns.2002.96.1.0079 
18. Schlienger M, Atlan D, Lefkopoulus D, Merienne L, Touboul E, Missir O, 
et al. LINAC radiosurgery for cerebral arteriovenous malformations: results 
in 169 patients. Int J Radiat Oncol Biol Phys (2000) 46:1135–42. doi:10.1016/
S0360-3016(99)00523-4 
19. Yamamoto Y, Coffey RJ, Nichols DA, Shaw EG. Interim report on the radio-
surgical treatment of cerebral arteriovenous malformations: the influence of 
size, dose, time, and technical factors on obliteration rate. J Neurosurg (1995) 
83:832–7. doi:10.3171/jns.1995.83.5.0832 
20. Zabel A, Milker-Zabel S, Huber P, Schulz-Ertner D, Schlegel W, Debus J. 
Treatment outcome after LINAC-based radiosurgery in cerebral arteriove-
nous malformations: retrospective analysis of factors affecting obliteration. 
Radiother Oncol (2005) 77:105–10. doi:10.1016/j.radonc.2005.04.008 
21. Zabel-du Bois A, Milker-Zabel S, Huber P, Schlegel W, Debus J. Risk 
of hemorrhage and obliteration rates of LINAC-based radiosurgery for 
cerebral arteriovenous malformations treated after prior partial embo-
lization. Int J Radiat Oncol Biol Phys (2007) 68:999–1003. doi:10.1016/j.
ijrobp.2007.01.027 
22. Alexander MJ, Tolbert ME. Targeting cerebral arteriovenous malformations for 
minimally invasive therapy. Neurosurgery (2006) 59:178–83. doi:10.1227/01.
NEU.0000238530.44912.01 
23. Chang SD, Marcellus ML, Marks MP, Levy RP, Do HM, Steinberg GK. 
Multimodality treatment of giant intracranial arteriovenous malformations. 
Neurosurgery (2003) 53:1–13. doi:10.1227/01.NEU.0000068700.68238.84 
24. Deruty R, Pelissou-Guyotat I, Mottolese C, Bascoulergue Y, Amat D. The 
combined management of cerebral arteriovenous malformations: experience 
with 100 cases and review of the literature. Acta Neurochir (Wien) (1993) 
123:101–12. doi:10.1007/BF01401864 
25. Andrade-Souza YM, Ramani M, Scora D, Tsao MN, ter Brugge K, Schwartz 
ML. Embolization before radiosurgery reduces the obliteration rate of arte-
riovenous malformations. Neurosurgery (2007) 60:443–52. doi:10.1227/01.
NEU.0000255347.25959.D0 
26. Pollock BE, Flickinger JC, Lunsford LD, Maitz A, Kondziolka D. Factors asso-
ciated with successful arteriovenous malformation radiosurgery. Neurosurgery 
(1998) 42:1239–47. doi:10.1097/00006123-199806000-00020 
27. Xu F, Zhong J, Ray A, Manjila S, Bambakidis NC. Stereotactic radiosurgery 
with and without embolization for intracranial arteriovenous malformations: 
a systematic review and meta-analysis. Neurosurg Focus (2014) 37:E16. 
doi:10.3171/2014.6.FOCUS14178 
28. Dawson RC III, Tarr RW, Hecht ST, Jungreis CA, Lunsford LD, Coffey R, 
et al. Treatment of arteriovenous malformations of the brain with combined 
embolization and stereotactic radiosurgery: results after 1 and 2 years. AJNR 
Am J Neuroradiol (1990) 11:857–64. 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2016 Sousa, Teixeira, Piske, Albuquerque, Côrrea, Benabou, Welling, 
de Sousa and Figueiredo. This is an open-access article distributed under the terms 
of the Creative Commons Attribution License (CC BY). The use, distribution or 
reproduction in other forums is permitted, provided the original author(s) or licensor 
are credited and that the original publication in this journal is cited, in accordance 
with accepted academic practice. No use, distribution or reproduction is permitted 
which does not comply with these terms.
